[Effect of recombinant interleukin 2 on peripheral blood lymphocytes in vitro. IV. Cytotoxicity of lymphocytes in patients with malignant tumors]. 1988

M Jíra, and J Strejcek, and J Faltýn, and Z Chodounský, and M Suchomelová, and M Tomásová, and E Zábojová, and M Procházka

UI MeSH Term Description Entries
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

M Jíra, and J Strejcek, and J Faltýn, and Z Chodounský, and M Suchomelová, and M Tomásová, and E Zábojová, and M Procházka
January 1997, Tsitologiia,
M Jíra, and J Strejcek, and J Faltýn, and Z Chodounský, and M Suchomelová, and M Tomásová, and E Zábojová, and M Procházka
August 1988, Immunology,
M Jíra, and J Strejcek, and J Faltýn, and Z Chodounský, and M Suchomelová, and M Tomásová, and E Zábojová, and M Procházka
May 1988, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
M Jíra, and J Strejcek, and J Faltýn, and Z Chodounský, and M Suchomelová, and M Tomásová, and E Zábojová, and M Procházka
April 1986, Cellular immunology,
M Jíra, and J Strejcek, and J Faltýn, and Z Chodounský, and M Suchomelová, and M Tomásová, and E Zábojová, and M Procházka
December 1989, The Bulletin of Tokyo Medical and Dental University,
M Jíra, and J Strejcek, and J Faltýn, and Z Chodounský, and M Suchomelová, and M Tomásová, and E Zábojová, and M Procházka
July 1989, The American journal of the medical sciences,
M Jíra, and J Strejcek, and J Faltýn, and Z Chodounský, and M Suchomelová, and M Tomásová, and E Zábojová, and M Procházka
January 1988, Lymphokine research,
M Jíra, and J Strejcek, and J Faltýn, and Z Chodounský, and M Suchomelová, and M Tomásová, and E Zábojová, and M Procházka
January 1990, Cancer immunology, immunotherapy : CII,
M Jíra, and J Strejcek, and J Faltýn, and Z Chodounský, and M Suchomelová, and M Tomásová, and E Zábojová, and M Procházka
December 1988, Annals of allergy,
M Jíra, and J Strejcek, and J Faltýn, and Z Chodounský, and M Suchomelová, and M Tomásová, and E Zábojová, and M Procházka
January 1997, Journal of clinical periodontology,
Copied contents to your clipboard!